Veterinary Medicines

Cylabel 1000 mg/g powder for use in drinking water/milk for cattle and pigs

Not authorised
  • Sodium salicylate
Download as PDF

Product identification

Medicine name:
Cylabel 1000 mg/g powder for use in drinking water/milk for cattle and pigs
Cylabel 1000 mg/g poeder voor gebruik in drinkwater/melk voor runderen en varkens
Active substance:
  • Sodium salicylate
Target species:
  • Cattle (pre-ruminant)
  • Pig
Route of administration:
  • In drinking water use
  • In drinking water/milk use
  • In drinking water/milk use

Product details

Active substance and strength:
  • Sodium salicylate
    1000.00
    milligram(s)
    /
    1.00
    gram(s)
Pharmaceutical form:
  • Oral powder
Withdrawal period by route of administration:
  • In drinking water use
    • Cattle (pre-ruminant)
      • Meat and offal
        0
        day
    • Pig
      • Meat and offal
        0
        day
  • In drinking water/milk use
    • Cattle (pre-ruminant)
      • Meat and offal
        0
        day
    • Pig
      • Meat and offal
        0
        day
  • In drinking water/milk use
    • Cattle (pre-ruminant)
      • Meat and offal
        0
        day
    • Pig
      • Meat and offal
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QN02BA04
Legal status of supply:
This information is not available for this product.
Authorisation status:
  • Surrendered
Authorised in:
  • Netherlands
Package description:
  • (ID2): 1 unspecified outer container with 1 Sachet (PolyEthylene, Paper, PolyEthylene, Aluminium, PolyEthylene) with 5 kilogram(s) (5 kilogram(s))
  • (ID1): 1 unspecified outer container with 1 Box (Paper, PolyEthylene, Aluminium, PolyEthylene) with 1 kilogram(s) (1 kilogram(s))

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Bela-Pharm GmbH & Co. KG
Marketing authorisation date:
Manufacturing sites for batch release:
  • Bela-Pharm GmbH & Co. KG
Responsible authority:
  • MEB
Authorisation number:
  • REG NL 120036
Date of authorisation status change:
Reference member state:
  • Germany
Procedure number:
  • DE/V/0169/001

Documents

Combined File of all Documents

English (PDF)
Published on: 31/08/2022
Download
Dutch (PDF)
Published on: 8/02/2022
Download

Summary of Product Characteristics

English (PDF)
Published on: 31/08/2022
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."